Sodium-dependent high affinity choline uptake: a regulatory step in the synthesis of acetylcholine.
D015107:4-Butyrolactone / Q000494:pharmacology; D000109:Acetylcholine / Q000096:biosynthesis*; D000818:Animals; D001693:Biological Transport, Active; D001921:Brain / Q000378:metabolism* / Q000502:physiology; D002697:Chloral Hydrate / Q000494:pharmacology; D002794:Choline / Q000378:metabolism*; D003342:Corpus Striatum / Q000378:metabolism; D006624:Hippocampus / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism; D008297:Male; D009928:Organ Specificity; D010095:Oxotremorine / Q000494:pharmacology; D010424:Pentobarbital / Q000494:pharmacology; D010433:Pentylenetetrazole / Q000494:pharmacology; D051381:Rats; D012601:Scopolamine / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology*; D013574:Synaptosomes / Q000187:drug effects / Q000378:metabolism*
D002697:Chloral Hydrate; D010095:Oxotremorine; D012964:Sodium; D012601:Scopolamine; D010424:Pentobarbital; D002794:Choline; D000109:Acetylcholine; D015107:4-Butyrolactone; D010433:Pentylenetetrazole